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1. Introduction
The diagnosis of sarcoidosis is based on clinico-radiological findings and histological evidence
of non-caseating epithelioid-cell granulomas [1]. Traditionally, if pulmonary sarcoidosis is
suspected, pathological diagnostic materials are often obtained using conventional bronchosco‐
py together with procedures such as bronchoalveolar lavage (BAL) for evaluation of disease
activity, transbronchial needle aspiration (TBNA) for hilar/mediastinal lymph node lesions,
transbronchial lung biopsy (TBLB) for lung parenchymal lesions, and transbronchial biopsy (TBB)
for endobronchial lesions. In most cases, however, definitive pathological diagnosis of this disease
mainly depends on TBLB for lung parenchymal lesions because hilar/mediastinal lymph node
lesions are often difficult to access and endobronchial lesions are uncommon. The diagnostic yield
of TBLB in this disease is reportedly about 40–90% when several biopsy samples are obtained [2,
3]. When mediastinal or hilar lymphadenopathy is detected on computed tomography (CT) and
cannot be diagnosed with conventional bronchoscopy, mediastinoscopy is performed to obtain
histological samples. Although the diagnostic sensitivity of this procedures is >90% [4, 5], it is
invasive and requires general anesthesia [5]. In this chapter, a newly developed bronchoscopic
technique, endobronchial ultrasonography (EBUS)-guided transbronchial needle aspiration
(EBUS-TBNA) for the definitive diagnosis of sarcoidosis is discussed.
2. EBUS-TBNA, a newly developed bronchoscopic technique
An  endobronchial  ultrasound,  recently  developed  in  Japan  [6,  7],  is  a  bronchoscope
equipped with a convex-type ultrasound probe at the tip of the scope to simultaneously
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visualize  endobronchial  images  with  optical-wavelength  light  and  images  of  peribron‐
chial structures, such as lymph nodes and vessels, with ultrasound (Figure 1). By introduc‐
ing a specialized TBNA needle into the forceps channel, it is possible to obtain cytological
and even histological samples [6, 7].  This technique was developed primarily as a novel
minimally invasive diagnostic technique for lymph node staging of lung cancer [6, 8- 17].
As  summarized in  Table  1,  initial  research  disclosed  its  high  sensitivity  and diagnostic
yields for this purpose. This new technique has obviated the need for classical and invasive
mediastinoscopy in many cases, and a current European guideline for lymph node staging
in  lung  cancer  primarily  recommends  EBUS-TBNA  over  mediastinoscopy  [18].  Recent
reports  also  indicate  that  EBUS-TBNA  is  a  valuable  diagnostic  method  for  pulmonary
sarcoidosis  with  hilar/mediastinal  lymphadenopathy  [19  -  32].  The  presence  of  non-
caseating  epithelioid-cell  granulomas  in  the  lymph  nodes  obtained  by  EBUS-TBNA
suggests the diagnosis of granulomatous disease including sarcoidosis.
Figure 1. A bronchoscopic procedure with EBUS. The operator and assistants can view simultaneous real-time images of
both endobronchus with natural light (right monitor) and peribronchial structures with ultrasonography (left monitor).
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Author Year No. ofpatients Study design
Sensitivity
(%)
Specificity
(%)
Yasufuku[6] 2005 108 Prospective 94.1 100
Yasufuku[10] 2006 102 Prospective 92.3 100
Herth[11] 2006 502 Prospective 94 100
Vincent[12] 2008 146 Retrospective 99.1 100
Wallace[13] 2008 138 Prospective 69 100
Herth[14] 2008 97 Prospective 88.9 100
Ernst[15] 2008 66 Prospective 88.1 100
Petersen[16] 2009 157 Retrospective 85 100
Yasufuku[17] 2011 102 Prospective 81 100
Table 1. Recent studies for staging of lung cancer with EBUS-TBNA
3. Technique to obtain histological and cytological materials with EBUS-
TBNA
EBUS-TBNA is performed under local anesthesia with mild sedation, which is compara‐
ble to conventional bronchoscopy [7 - 11]. Contrast medium-enhanced CT images are used
to identify target lymph nodes. A convex-probe-equipped EBUS bronchoscope (CP-EBUS;
for example, BF-UC260F-OL8; Olympus, Tokyo, Japan) supported by an ultrasound image
processor (model EU-C2000; Olympus) and a dedicated 22- or 21-gauge aspiration needle
(NA-201SX-4022/NA-201SX-4021; Olympus) are used (Figures 2, 3). Although 21 G and 22
G needles yield similar sensitivity in the diagnosis of malignant diseases, 22 G needles are
more efficient than 21 G needles for obtaining materials from patients with sarcoidosis [33].
While  the target  lymph node is  visualized with EBUS,  a  transbronchial  puncture under
real-time ultrasound guidance is performed with a needle equipped with an internal sheath
(Figure 4).  The internal  sheath prevents clogging of  the needle with bronchial  epithelial
cells. On confirming that the tip of the needle has penetrated the target lymph node, the
internal sheath is removed, and rapid negative pressure is applied by aspirating with a 20-
mL syringe several times. After the needle is moved back and forth inside the lymph node
under real-time ultrasound guidance, it is retrieved and the internal sheath is used to expel
the material aspirated in the needle (Figure 5). A histological core is first obtained in many
cases; this material is placed on a small piece of filter paper for fixation in 10% buffered
formalin. The internal sheath is then removed, and positive pressure is applied using an
air-filled 20-mL syringe to expel the remaining material in the needle onto a glass slide,
which  is  then  smeared  against  another  glass  slide  by  using  the  squash  preparation
technique to yield cytological smears on 2 glass slides (Figure 6).  Both histological cores
and cytological  specimens are obtained in many cases  with this  method.  In our institu‐
tion,  tentative  on-site  cytological  diagnosis  by  a  cytoscreener  is  available.  One  of  the
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cytological  slides  is  placed in  95% ethanol  for  fixation  and staining  with  the  Papanico‐
laou technique.  The other one is  air-dried,  stained with a Romanowsky-type stain (Diff-
Quik®), and sent for on-site evaluation. The cytoscreener ensures that the specimen is of
adequate  quality.  Tissue  sampling  is  repeated  until  sufficient  material  is  obtained.  The
aspirated  materials  can  also  be  dispersed into  sterile  saline  solution  for  microbiological
examinations,  including staining and culture  for  bacteria,  fungi,  and acid-fast  bacilli.  In
addition,  polymerase  chain reaction examinations  can be  performed for  acid-fast  bacilli.
Histological diagnoses are based on the results of hematoxylin and eosin (H-E) staining.
Figure 2. The tip of the endobronchial ultrasound equipped with an aspiration needle (asterisk). The needle is pro‐
truded for demonstration.
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Figure 3. The control head of an endobronchial ultrasound is similar to that of a conventional bronchoscope except
for a sophisticated needle aspiration kit that enables operators to control internal and outer sheaths separately.
Figure 4. An ultrasound image showing an enlarged lymph node (hypoechoic area; arrowheads) and an aspiration
needle (arrow) inserted into the lymph node. On ensuring that the tip of the needle is inside the target lymph node,
negative pressure is applied and the needle is moved back and forth inside the lymph node to obtain material for
pathological examination.
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Figure 5. Aspirated material inside the needle is expelled by inserting the inner sheath. Usually a histological core is
obtained, and the material is collected on a filter paper for fixation in formalin solution.
Figure 6. After obtaining the histological core, the inner sheath is removed. An abrupt positive pressure is used to
expel remaining material inside the needle for cytological samples, which are obtained on 2 glass slides by using the
squash preparation technique.
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BAL followed by TBLB with conventional bronchoscopy is performed before EBUS-TBNA
[22,28] when required.
4. Sensitivity and specificity of EBUS-TBNA in the diagnosis of sarcoidosis
Table 2 summarizes the results of recent reports and shows a diagnostic sensitivity for
sarcoidosis of EBUS-TBNA ranging from 56% to 94% [19 - 32]. Non-caseating epithelioid-cell
granulomas on histological examination of EBUS-TBNA specimens have high sensitivity and
specificity for sarcoidosis at stages 1 and 2. Nakajima et al. [22], Oki et al. [28], and Kitamura
et al. [29] reported that the sensitivity of EBUS-TBNA for stage 1 and 2 sarcoidosis is much
higher than that of TBLB from the lung parenchyma.
Author Year
No. of
patients
Study design
Histology Cytology Histology & Cytology
Sensitivity
(%)
Specificity
(%)
Sensitivity
(%)
Specificity
(%)
Sensitivity
(%)
Specificity
(%)
Garwood[19] 2007 48 Prospective - - - - 85 -
Oki[20] 2007 14 Prospective 57 - 65 - 78 -
Wong[21] 2007 61 Prospective - - - - 92 -
Nakajima[22] 2009 32 Retrospective 63 - 71 - 91 -
Tremblay[23] 2009 24 Prospective - - - - 83 -
Eckardt[24] 2010 43 Retrospective - - - - 77 -
Tournoy[25] 2010 54 Prospective - - - - 56 -
Navani[26] 2011 27 Prospective - - - - 85 -
Plit[27] 2011 37 Retrospective - - - - 84 -
Oki[28] 2012 54 Prospective - - - - 94 -
Kitamura[29] 2012 72 Retrospective 72 97 65 94 88 92
- : not available
Table 2. Recent studies for diagnosis of sarcoidosis with EBUS-TBNA
5. Diagnostic validity for sarcoidosis of epithelioid-cell clusters on
cytological examination
Cytological evaluation has been reported in the diagnosis of sarcoidosis with conventional
TBNA, trans-esophageal ultrasound-guided biopsy [34 - 40], and EBUS-TBNA [41,42];
however, the validity of the diagnostic criteria has not been defined.
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Epithelioid-cell clusters suggesting the presence of granulomas are defined by variably-sized
loose collections of non-pigmented epithelioid or spindle-cell histiocytes that are usually
accompanied by lymphocytes [31]. Typical cytological findings are shown in Figures 7 to 10,
together with their corresponding histological findings obtained from the same aspiration. The
validity of cytological evaluation in the diagnosis of sarcoidosis, however, was not well-
defined. To elucidate the diagnostic validity of epithelioid-cell clusters on cytological exami‐
nation, we performed a study in which cytological samples from 72 patients with sarcoidosis
and 116 control patients with malignant lung diseases mainly of primary lung cancer (with
lymphadenopathy eventually proven to be metastasis free) were evaluated independently by
2 cytoscreeners and a pathologist, all blinded to patient information. The results included
excellent inter-observer variability and a high specificity of 94.0%, indicating validity of
cytological diagnosis of sarcoidosis [29]. Our study also uncovered a very high rate (87.5% or
63/72) of pathological proof of epithelioid-cell granulomas when cytological and histological
evaluations with EBUS-TBNA-obtained materials were combined. Validity of cytological
diagnosis of sarcoidosis might be applicable to other organs.
Figure 7. Typical epithelioid-cell clusters in a cytological specimen, with Diff-Quik staining (a and b) and Papanicolaou
staining (c and d). They were obtained from the same lymph node in a patient with sarcoidosis. The original magnifi‐
cations were ×100 (a and c) and ×400 (b and d).
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Figure 8. Histological findings of a histological core obtained from the same patient whose cytological findings are
shown in Figure 7. Histological findings characteristic of a non-caseating epithelioid-cell granuloma are shown (H-E
stain; original magnification of ×100 in a and ×200 in b).
Figure 9. Normal lymph node findings shown in a cytological specimen, with Diff-Quik staining (a and b) and Papani‐
colaou staining (c and d). They were obtained from the same lymph node in a control patient. The original magnifica‐
tion were ×100 (a and c) and ×400 (b and d).
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Figure 10. Histological findings of a histological core obtained from the same patient whose cytological findings are
shown in Figure 9. Although the structure has partially disintegrated probably because of tissue damage inside the
aspiration needle, normal lymph node architecture is observed without evidence of epithelioid-cell granuloma or ma‐
lignant cells (H-E stain; original magnification of ×100 in a and ×200 in b).
6. Epithelioid-cell granulomas in lymphadenopathy with lung cancer
Non-caseating epithelioid-cell granulomas may be seen in draining lymph nodes in various
malignant diseases. These relatively uncommon histological findings, which are not systemic
sarcoidosis, have been termed sarcoid reactions [43]. Sarcoid reactions are also seen in lung
malignancy with a reported incidence of 1.2–4.3% [44- 46]. This value was 6.0% in our study
[29], that is, cytological evaluation of the EBUS-TBNA samples revealed epithelioid-cell
clusters in lymph nodes from 7 patients out of the 116 patients with primary lung cancer whose
lymphadenopathy was eventually proven to be metastasis free. Sarcoid reactions probably
reflect an immune response to tumor antigens due to T-cell mediated immune responses [47].
The tumor antigens are thought to be carried by lymphatic vessels to the draining lymph nodes,
causing sarcoid reactions in situ [43]. Although uncommon, it is very important that this is
considered in the pathological diagnosis of sarcoidosis. There is no report on differentiating
sarcoidosis from sarcoid reactions on the basis of histological and/or cytological findings.
Clinical differentiation of sarcoid reaction from sarcoidosis, however, may not be difficult
because of the presence of primary lesion and asymmetric distribution of the hilar/mediasti‐
num lymphadenopathy. Nevertheless, it should be stressed that sarcoid reaction potentially
misleads N staging of the lung cancer.
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7. Future directions
As discussed in the above sections, EBUS-TBNA results in a very high rate (>80%) of patho‐
logical proof of sarcoidosis provided enlarged hilar/mediastinal lymph nodes are accessible.
The technique has been reported to be very safe because target lymph nodes and surrounding
vessels are easily visualized with ultrasound images. In contrast, the sensitivity of TBLB of
pulmonary parenchymal lesions is reportedly much lower than that with EBUS-TBNA. In fact,
it was 34.5% (or 20/58) in our study [29], where only 58 patients out of the 72 patients with
sarcoidosis were evaluated with TBLB because of absent pulmonary lesions in the imaging
studies and/or possible complications. TBLB is potentially invasive; consequently, the proce‐
dure may be complicated with massive bleeding or pneumothorax. These possible complica‐
tions may justify avoiding TBLB in the diagnosis of sarcoidosis when EBUS-TBNA is available.
Excluding certain conditions where proof of pulmonary parenchymal lesions is required,
prioritizing EBUS-TBNA over TBLB would be reasonable. Advances in this new technology
might change the diagnostic practices in sarcoidosis.
In addition, easier access to involved lymph nodes with EBUS-TBNA may provide new
opportunities to obtain biomarkers for elucidating pathogenesis of the disease. In fact,
Nakajima et al. [48] and Sakairi et al. [49] were successful with this technique in detecting
various gene mutations in patients with lung cancer. Similar advances with the same technique
in the field of sarcoidosis and other granulomatous diseases would be realistic. We anticipate
that sarcoidosis, an unpleasant refractory disease, will be conquered by applied investigation
and personalized care in the future.
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